Legend Biotech Corporation
LEGN
$34.86
$1.374.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.65% | -67.73% | 31.13% | -14.17% | 53.17% |
| Total Depreciation and Amortization | 89.15% | 34.58% | 16.79% | 2.92% | 4.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 166.98% | 3,946.29% | 27.98% | 498.08% | -44.71% |
| Change in Net Operating Assets | 36.64% | -608.21% | -305.68% | -323.29% | -374.27% |
| Cash from Operations | 69.01% | 30.52% | -7.80% | -92.47% | -10.30% |
| Capital Expenditure | -246.00% | -102.82% | -15.74% | 19.20% | 55.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 269.71% | 188.24% | 100.52% | 139.81% | 36.76% |
| Cash from Investing | 244.03% | 183.42% | 95.26% | 137.19% | 38.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.00% | 9.43% | -28.98% | -24.29% | -9.27% |
| Issuance of Common Stock | -79.43% | -66.43% | -63.71% | 9.45% | -98.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -139.62% | -106.44% | -100.73% | -4.03% | -99.31% |
| Foreign Exchange rate Adjustments | 1,080.39% | 390.48% | 288.56% | 1,112.80% | -113.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 144.91% | 162.08% | 64.23% | 106.33% | -291.92% |